IV Phenytoin (Dilantin) Dosing in Dialysis Patients
No dosage adjustment of IV phenytoin is required for patients undergoing dialysis as it is minimally removed by hemodialysis and has negligible renal excretion.
Pharmacokinetic Considerations
Phenytoin (Dilantin) has several important pharmacokinetic properties that impact its use in dialysis patients:
- Phenytoin is primarily metabolized by the liver (>95%)
- It has minimal renal excretion in its active form
- It is highly protein-bound (90-95%)
- It is minimally removed by hemodialysis
Dosing Recommendations
Loading Dose
- Standard loading dose: 15-20 mg/kg IV at a maximum rate of 50 mg/minute
- No adjustment needed for renal impairment or dialysis status
Maintenance Dose
- Standard maintenance dose: 4-6 mg/kg/day (typically 300-400 mg/day divided into 1-3 doses)
- No adjustment needed for renal impairment or dialysis status
Important Monitoring Considerations
Free (unbound) phenytoin levels should be monitored rather than total levels in dialysis patients
- Uremia can decrease protein binding, leading to higher free phenytoin concentrations
- Target free phenytoin level: 1-2 μg/mL (which corresponds to total level of 10-20 μg/mL in patients with normal protein binding)
Timing of levels:
- Draw levels at steady state (typically 3-5 days after starting therapy)
- For hemodialysis patients, draw levels before dialysis sessions
Special Considerations for Dialysis Patients
- Hypoalbuminemia: Common in dialysis patients and increases free phenytoin concentration
- Drug interactions: Many medications used in ESRD can affect phenytoin levels
- Cardiovascular risk: Monitor for hypotension during IV administration, especially in hemodynamically unstable dialysis patients
- Fosphenytoin alternative: Can be administered at a faster rate (150 mg PE/minute) with less cardiovascular risk
Administration Precautions
- Administer IV phenytoin slowly (maximum 50 mg/minute) to avoid cardiovascular collapse
- Use 0.9% saline or D5W for dilution (phenytoin precipitates in dextrose solutions)
- Flush IV line before and after administration
- Monitor blood pressure and cardiac rhythm during administration
Common Pitfalls to Avoid
- Adjusting dose based on creatinine clearance (unnecessary)
- Relying on total phenytoin levels rather than free levels
- Administering IV phenytoin too rapidly
- Failing to account for hypoalbuminemia when interpreting levels
While phenytoin requires no specific dosage adjustment for dialysis patients, careful monitoring of free drug levels and attention to administration precautions are essential to ensure both efficacy and safety in this vulnerable population.